These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 36060977)

  • 21. Prediction of response to neoadjuvant chemotherapy in advanced gastric cancer: A radiomics nomogram analysis based on CT images and clinicopathological features.
    Tan X; Yang X; Hu S; Ge Y; Wu Q; Wang J; Sun Z
    J Xray Sci Technol; 2023; 31(1):49-61. PubMed ID: 36314190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nomogram for predicting axillary pathologic complete response in hormone receptor-positive breast cancer with cytologically proven axillary lymph node metastases.
    Guo R; Su Y; Si J; Xue J; Yang B; Zhang Q; Chi W; Chen J; Chi Y; Shao Z; Wu J
    Cancer; 2020 Aug; 126 Suppl 16():3819-3829. PubMed ID: 32710664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer.
    Jiang M; Li CL; Luo XM; Chuan ZR; Lv WZ; Li X; Cui XW; Dietrich CF
    Eur J Cancer; 2021 Apr; 147():95-105. PubMed ID: 33639324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy.
    Garufi G; Carbognin L; Sperduti I; Miglietta F; Dieci MV; Mazzeo R; Orlandi A; Gerratana L; Palazzo A; Fabi A; Paris I; Franco A; Franceschini G; Fiorio E; Pilotto S; Guarneri V; Puglisi F; Conte P; Milella M; Scambia G; Tortora G; Bria E
    Ther Adv Med Oncol; 2023; 15():17588359221138657. PubMed ID: 36936199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of radiomics based on CE-MRI for predicting the efficacy of neoadjuvant chemotherapy in invasive breast cancer.
    Li Q; Huang Y; Xiao Q; Duan S; Wang S; Li J; Niu Q; Gu Y
    Br J Radiol; 2022 Oct; 95(1139):20220186. PubMed ID: 36005646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can We Reliably Identify the Pathological Outcomes of Neoadjuvant Chemotherapy in Patients with Breast Cancer? Development and Validation of a Logistic Regression Nomogram Based on Preoperative Factors.
    Zhang J; Xiao L; Pu S; Liu Y; He J; Wang K
    Ann Surg Oncol; 2021 May; 28(5):2632-2645. PubMed ID: 33095360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Model of D2 Radical Gastrectomy Combined with Neoadjuvant Chemotherapy for Gastric Cancer.
    Wang G; Tan Y; Jiang Y; Liu J; Su Y; Sun Z; Liu B
    Risk Manag Healthc Policy; 2023; 16():1259-1271. PubMed ID: 37456825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model].
    Jiang W; Feng MY; Dong XY; Dong SM; Zheng JX; Liu XM; Liu WJ; Yan J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):748-754. PubMed ID: 31422613
    [No Abstract]   [Full Text] [Related]  

  • 29. Development and validation of a nomogram based on pretreatment dynamic contrast-enhanced MRI for the prediction of pathologic response after neoadjuvant chemotherapy for triple-negative breast cancer.
    Li Y; Chen Y; Zhao R; Ji Y; Li J; Zhang Y; Lu H
    Eur Radiol; 2022 Mar; 32(3):1676-1687. PubMed ID: 34767068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction of Nomograms for Predicting Pathological Complete Response and Tumor Shrinkage Size in Breast Cancer.
    Yan S; Wang W; Zhu B; Pan X; Wu X; Tao W
    Cancer Manag Res; 2020; 12():8313-8323. PubMed ID: 32982426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysis.
    Jankowski C; Guiu S; Cortet M; Charon-Barra C; Desmoulins I; Lorgis V; Arnould L; Fumoleau P; Coudert B; Rouzier R; Coutant C; Reyal F
    Breast Cancer Res Treat; 2017 Jan; 161(1):73-81. PubMed ID: 27807808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study.
    Zhang H; Xie P; Li Z; Huang R; Feng W; Kong Y; Xu F; Zhao L; Song Q; Li J; Zhang B; Fan J; Qiao Y; Xie X; Zheng S; He J; Wang K
    Diagn Pathol; 2019 May; 14(1):35. PubMed ID: 31054583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative Breast Immune Prognostic Index as Prognostic Factor Predicts the Clinical Outcomes of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Chen L; Kong X; Huang S; Su Z; Zhu M; Fang Y; Zhang L; Li X; Wang J
    Front Immunol; 2022; 13():831848. PubMed ID: 35320931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasound and clinicopathological characteristics-based model for prediction of pathologic response to neoadjuvant chemotherapy in HER2-positive breast cancer: a case-control study.
    Sui L; Yan Y; Jiang T; Ou D; Chen C; Lai M; Ni C; Zhu X; Wang L; Yang C; Li W; Yao J; Xu D
    Breast Cancer Res Treat; 2023 Nov; 202(1):45-55. PubMed ID: 37639063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiomic Nomogram for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer: Predictive Value of Staging Contrast-enhanced CT.
    Huang X; Mai J; Huang Y; He L; Chen X; Wu X; Li Y; Yang X; Dong M; Huang J; Zhang F; Liang C; Liu Z
    Clin Breast Cancer; 2021 Aug; 21(4):e388-e401. PubMed ID: 33451965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Nomogram for Predicting the Pathological Response of Axillary Lymph Node Metastasis in Breast Cancer Patients.
    Jin X; Jiang YZ; Chen S; Shao ZM; Di GH
    Sci Rep; 2016 Aug; 6():32585. PubMed ID: 27576704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative systemic inflammation response index: Clinicopathologic predictor of pathological complete response in HER2-positive breast cancer patients receiving neoadjuvant systemic therapy.
    Wu HY; Lin CY; Tzeng YD; Hung CC; Liu SI; Yin CH; Chen JS; Chen YS; Yang JR
    J Chin Med Assoc; 2024 Feb; 87(2):226-235. PubMed ID: 38095571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and Validation of a Serum Albumin-to-Alkaline Phosphatase Ratio-Based Nomogram for Predicting Pathological Complete Response in Breast Cancer.
    Qu F; Li Z; Lai S; Zhong X; Fu X; Huang X; Li Q; Liu S; Li H
    Front Oncol; 2021; 11():681905. PubMed ID: 34692474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nomogram prediction of the 70-gene signature (MammaPrint) binary and quartile categorized risk using medical history, imaging features and clinicopathological data among Chinese breast cancer patients.
    Pan B; Xu Y; Yao R; Cao X; Zhou X; Hao Z; Zhang Y; Wang C; Shen S; Luo Y; Zhu Q; Ren X; Kong L; Zhou Y; Sun Q
    J Transl Med; 2023 Nov; 21(1):798. PubMed ID: 37946210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nomogram based on platelet-to-lymphocyte ratio for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy.
    Ma R; Wei W; Ye H; Dang C; Li K; Yuan D
    BMC Cancer; 2023 Mar; 23(1):245. PubMed ID: 36918796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.